Fundraising FoxJohnson & Johnson Innovation – JJDC
Corporate VCNew Brunswick · Seed–Growth · 41 people tracked
Find your way into Johnson & Johnson Innovation – JJDC
Each arrow is one introduction. Sign up to fill in the first one.
Ask Alex Baron to introduce you to Anurag Mehta
You →Alex · together at Ovia Health →Anurag
Ask Jamie Chen to introduce you to Tamir Meiri
You →Jamie · together at Ovia Health →Tamir
Ask Sam Okafor to introduce you to Rowan Chapman
You →Sam · together at GE Ventures →Rowan
- Asish K. Xavier687 people can intro you
- Marian Nakada492 people can intro you
- Juan Cueva383 people can intro you
Sign up to find every way you can get introduced to Johnson & Johnson Innovation – JJDC
- Your email: who you already know at Johnson & Johnson Innovation – JJDC, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Johnson & Johnson Innovation – JJDC team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Johnson & Johnson Innovation seeks to unlock the potential of life science innovation regardless of where it originates. It pairs Johnson & Johnson's internal expertise with promising external innovation from around the world to solve major health challenges and drive scientific breakthroughs. The organization operates across the innovation lifecycle: forming early innovation partnerships to accelerate early-stage ideas, incubating startups through its global JLABS network and community of innovators, providing venture capital through JJDC, and building late-stage partnerships offering access, resources, expertise, and commitment.
Source: firm website, verified Aug 3, 2026.
Team · 41 people
from the firm's website & public directories
Founder mafia
2 people who came through Johnson & Johnson Innovation – JJDC went on to found or lead other companies.
What they invest in
from 48 of 61 portfolio companiesHealthtech ×32Biotech ×30Medical Devices ×14AI & Machine Learning ×8Deep Tech ×6Digital Health ×6Data & Infrastructure ×3Consumer ×2
HQs:United States×32United Kingdom×3France×2Ireland×1Jamaica×1South Korea×1
Investments · 61 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 32023 · 72022 · 62021 · 32020 · 32019 · 12018 · 12017 · 22016 · 12015 · 141 dated
Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.
BiotechHealthtechMilpitas, US
Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)
BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)
Co-investorsAisling CapitalCanaan PartnersJJDCLilly VenturesRA CapitalStarfish Ventures
Rapport is a biopharmaceutical company developing novel therapeutics.
BiotechHealthtechMedical Devices
Abe Ceesay(President)Cheryl GaultinDr. SevignyAbraham N. Ceesay(President and Chief Executive Officer and Director)Steven Paul David Bredt(Founder)
Co-investorsARCH Venture PartnersSofinnova VenturesCapital GroupThird Rock Ventures
Biotech
Co-investorsKurma PartnersSofinnova PartnersM VenturesSR One Capital ManagementEQT Life Sciences
Bright Peak Therapeutics is a biotechnology company developing multi-functional PD-1 inhibitors for cancer immunotherapy, based on its EDC protein-engineering platform.
BiotechHealthtechSan Diego, US
Vijaya Pattabiraman(Founder)inJeffrey Bode(Founder)inFredrik Wiklund(Chief Executive Officer)Christine Siu(Director)Michael Rosenzweig(Director)Bertolt Kreft(Executive Officer)
Co-investorsRA CapitalVersant VenturesVenrockAlexandriaBlackRockFidelity Investments+2 more
Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.
BiotechHealthtechMedical DevicesOss, NL
Renato Chirivi(Co-founder (former CSO))in
BoardPaul Peter Tak(Chair of the Board)
Co-investorsBioGeneration VenturesPureos BioventuresSeventure PartnersForbionBOMCurie Capital+1 more
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtechSan Carlos, US
Anthony Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)Liam Ratcliffe(Director)in
BoardRon Hunt(Director)inLoretta Tse, Ph.D.(Director)
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupNew Leaf Venture PartnersPappas Capital+2 more
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)
Co-investorsSeroba Life SciencesEnterprise IrelandLaunch Capital
Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.
AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB
Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in
Co-investorsGV (Google Ventures)SV Health InvestorsForbionNorthpond VenturesJJDC
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.
BiotechHealthtechMedical DevicesAnn Arbor, US
David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in
BoardAaron Fletcher(Director)in
Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersInFocus Capital Partners, LLC+3 more
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.
BiotechHealthtechMedical Devices
Co-investorsArboretum VenturesMaverick Ventures IsraelVisionary VenturesCatalio Capital ManagementLifeSci Venture PartnersSequoia Capital+1 more
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease.
AI & Machine LearningDeep TechHealthtechMedical DevicesBedford, US
Eman Namati(President & CEO)inGuillermo Tearney(Founder; Professor of Pathology, Massachusetts General Hospital)Gregg Stone(Founder; Professor of Medicine, Mount Sinai Heart Health System)James Muller(Founder; Cardiologist, Brigham and Women's Hospital)inJeffrey O'Donnell(Founder; Managing General Partner, Runway Healthcare)Vivek Walimbe(Chief Operating Officer)in
Co-investorsLumira VenturesS3 VenturesSV Health InvestorsDeerfield Management Company
Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.
BiotechDeep TechHealthtechGaithersburg, US
Samir N. Khleif(Founder & CEO)inRamy Ibrahim(Chief Medical and Strategy Officer)inMikayel Mkrichyan(Senior Vice President of Science and Discovery)Sarah Sharman(Vice President of IP Legal Affairs)
BoardSean Parker(Director)Elena Viboch(Director)in
Board seatNancy Ondovik· per SEC Form D · $131.9M raise · filed Aug 2026
Co-investorsCatalio Capital Management, LPGeneral CatalystHAWKTAILLauder PartnersPrevail Venture CapitalAlexandria+3 more
.png)
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupAbbVie+3 more
Alessa develops SaaS compliance software that combines KYC, KYB, AML, and fraud prevention tools for financial institutions and corporates globally.
CybersecurityEnterprise SoftwareFintechSaaSJamaica, JM
Holly Sais Phillippi(Chief Executive Officer)in
Co-investorsMassMutual VenturesMission BiocapitalSalesforce VenturesWavecrest Growth Partners
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.
BiotechHealthtechPhiladelphia, US
Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)
BoardElizabeth Anderson(Director)Bruce Peacock(Director)
Co-investorsAvego BioScience CapitalHealthCapAgent CapitalBiotechnology Value FundCowen Healthcare InvestmentsNorthpond Ventures
ARO Network is an edge network infrastructure platform designed for AI agents to operate on local devices and residential networks using users' real-world resources.
AI & Machine LearningCrypto & Web3Data & Infrastructure
Co-investorsCVP NoLimitEv3 Ventures LlcNo Limit Holdings (NLH)17SigmaNorte VenturesOnevc Venture Partners Llc
Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency.
BiotechDeep TechMedical DevicesParis, FR
Jérémie Laurent(Chief Executive Officer)
Co-investorsAdBio partnersM Ventures
Developer of a surgical robotic system for minimally invasive endoscopy and laparoscopy
Frederic Moll(Founder)
Co-investorsBeast VenturesLux CapitalMithril Capital ManagementPractica CapitalSBI Investment Korea Co. Ltd.Sonder Capital+3 more
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.
BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Vamsee Pamula(Executive Officer, Director)in
BoardDennis Sacha(Director)William A. Hawkins(Director)
Co-investorsCharlotte Angel FundDuke Capital PartnersIAG Capital PartnersRex Health VenturesSolas BioVenturesVentureSouth+1 more
Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.
Advanced ManufacturingBiotechRoboticsCambridge, GB
Alex Lang(Founder)
Co-investorsHighland EuropeNYBC VenturesTTP VenturesBusiness Growth Fund
Cornerstone provides expert-guided AI software that organizes, standardizes, and harmonizes life science data from clinical trials, labs, and EHRs to produce analysis-ready datasets.
AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtech
Andrew Howland(Founder)inClara Oromendia(Founder)inViraj NarayananinMichael Elashoff(Founder)
Co-investorsAcrew CapitalHealthy VenturesInitiate Venture Partners
Covid test maker that went public at a $2.3 billion valuation.
Clint Sever(Founder)in
Co-investorsACME CapitalDarwin CapitalDecheng CapitalDentsu VenturesForesite CapitalMothership VC+4 more
Datavant Connect is a data connectivity platform that enables healthcare and life sciences organizations to share and link datasets while maintaining privacy compliance through tokenization technology.
AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtech
Kyle Armbrester(Chief Executive Officer)in
Co-investorsFlex Capital PartnersGrand VenturesHealth Catalyst CapitalMerck Global Health Innovation FundMSD Global Health Innovation FundOctave+3 more
Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome.
AI & Machine LearningBiotechSouth San Francisco, US
Chris Varma, Ph.D.(Executive Officer, Director)Chris Varma(Co-founder, Chairman and CEO)inJim Winkler(Executive Officer)Johannes Hermann, Ph.D.(Executive Officer)Kevin Webster(Executive Officer)inGregory Chow(Executive Officer)
Co-investorsBerkeley CatalystDCVC (Data Collective)Droia VenturesFelicis VenturesMPM BioImpactRA Capital+2 more
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesPivotal Life SciencesSeroba Life SciencesVenture Ontario+6 more
BiotechSan Diego, US
Han Ying(Director)Usman Nassim(Director)Weiguo Yu(Executive Officer)Renate Parry(Director)Ying Luo(Director)inSongjiang Ma(Director, Executive Officer)
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.
BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB
Thomas Davison(Executive Officer, Director)inM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)
Co-investorsAlpha Wave GlobalAmzak HealthArboretum VenturesEarly Stage Partners, LPHealthQuest CapitalK5 Global+7 more
HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.
HealthtechMedical DevicesLexington, US
Carl Vause(Executive Officer, Director)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)
BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in
Co-investorsCanaan PartnersOUP (Osage University Partners)Treo Ventures, LlcOsage University Partners
iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.
BiotechDeep TechHealthtechMedical Devices
Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in
Co-investorsInkef3B Future Health FundM VenturesVI PartnersXGEN Venture
MEMEBOX (미미박스/MBX) is a global beauty company that builds and sells K-beauty brands and products, marketed to consumers in over 40 countries.
ConsumerDirect to ConsumerE-commerceSeoul, KR
Hyungseok (Dino) Ha(Founder)inHyungseok Ha(CEO / Representative)inDino Ha(Founder)
Co-investorsClick VenturesCota CapitalCowboy VenturesFundersClubMontage CapitalOrbiMed+14 more
Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.
HealthtechMedical DevicesRoboticsParis, FR
Brice Gayet(Founder)inAnne Osdoit(Chief Executive Officer)inEric Ermenault(Chief Commercial Officer)inAnne Renevot(Chief Financial Officer)inViola Fleig(Chief Operations Officer)inDavid Noonan(Chief Technology Officer)in
Co-investorsNVIDIASofinnova PartnersCathay HealthStar51 CapitalNVentures
HealthtechPleasanton, US
Ted Lamson(Founder)inDavid Amerson(Executive Officer, Director)William Facteau(Director)Joshua Makower(Director)Theodore Lamson(Founder)
BoardRyan Drant(Director)
Co-investorsNew Enterprise Associates (NEA)Windham Capital Partners
Modern nail care brand offering high-quality, salon-grade products and tools for at-home manicures and pedicures.
Beverly Hills, US
Sarah Gibson Tuttle(Executive Officer, Director)in
Co-investorsAlpha Edison
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
BiotechHealthtechMedical DevicesMalvern, US
Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)Jonathan Mow(Chief Executive Officer)in
BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)
Co-investorsMountain Group CapitalNew Enterprise Associates (NEA)Hatteras Venture Partners
HealthtechBelmont, US
Barry Cheskin(Executive Officer, Director)S. Arieh Zak(Executive Officer)George Green(Executive Officer)
BoardDrew Schiff(Director)Michael Carusi(Director)Lou Bock(Director)
Co-investorsAisling CapitalArcher Capital GroupArcher Venture CapitalLightstone VenturesFrazier Life SciencesScale Venture Partners
HealthtechHouston, US
Joanna Nathan(Executive Officer, Director)in
BoardMicheal Haimour(Director)Ed Boyle(Director)Sean Churchill(Director)
Co-investorsHouston Angel NetworkNew World AngelsTMC Venture Fund
Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.
BiotechHealthtech
Pete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDavid Mantusin
Co-investorsAdjuvant CapitalAsahi Kasei Corporate Venture CapitalDementia Discovery FundF-Prime CapitalJeito CapitalLongwood Fund+4 more
Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.
BiotechHealthtech
Shelley Force Aldred(Co-Founder & Chief Executive Officer)inNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)
Co-investorsCanaan PartnersDementia Discovery FundRed Tree VentureSV Health InvestorsNovo Holdings
Rosebud AI provides generative AI tools that enable users to create games and immersive interactive experiences without requiring extensive technical expertise.
AI & Machine LearningConsumerCreator EconomyDeveloper ToolsGamingSan Francisco, US
Co-investors2am VCAngel Collective Opportunity FundFoothill VenturesKhosla VenturesSoma CapitalVentek+15 more
Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.
Medical DevicesCollege Station, US
James Y Lancaster(Executive Officer, Director)in
BoardJohn Hodock(Director)Robert Calvin Goforth(Director)
Co-investorsShangBay Capital LLCSugati Ventures
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesLeaps by BayerARCH Venture PartnersFoothill VenturesIllumina VenturesMedical Excellence Capital+8 more
HealthtechLexington, US
Michael Cima, Ph.D.(Director)Rahul Dhanda(Senior Vice President, Corporate Development)inJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in
Co-investorsAisling CapitalAPERTURE Venture PartnersArcus VenturesFlagship VenturesFlybridge Capital PartnersPolaris Partners+1 more
Astoria, US
Demetrius Michael Karagas(Executive Officer, Director)Steven Gutentag(Founder)inDemetri Karagas(Founder)
BoardRebecca Kaden(Director)in
Co-investorsAlpha PartnersAlumni VenturesComcast VenturesConnetic VenturesCVS Health VenturesEvolution VC Partners+18 more
Transforming the lives of patients through a functional cure for Type 1 Diabetes
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in
Co-investorsArtis VenturesATEL VenturesBain Capital Life SciencesRA CapitalSanderling VenturesThe Vertical Group+1 more
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in
BoardTerry Lierman(Director)
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementMSD Global Health Innovation Fund+2 more
Yup is a cross-posting tool that lets users publish a single post to multiple social platforms—including Twitter, Farcaster, Lens, and Bluesky—with one click.
Crypto & Web3Social
Co-investorsLD CapitalSevenX Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ApoGen BiotechnologiesAquinox PharmaceuticalsMadisonMetaphysic AIMomenta PharmaceuticalsPerceive BiotherapeuticsPetra PharmaRevision OpticsSail BiomedicinesSpinal ModulationSpringWorks TherapeuticsVeracyte, Inc.X-Vax Technology
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
2 IPOs · 2 acquisitions · showing 2Protagonist TherapeuticsNASDAQ: PTGXRapport TherapeuticsNASDAQ: RAPP
Portfolio news
latest coverage across their companies
Alessa · fintech.global · Sep 18, 2026
SonoThera · finsmes.com · Jun 10, 2026
Mestag · finsmes.com · Mar 17, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Rapport Therapeutics | 7.1% | $17.00 | Jun 2024 | $42.5M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Johnson & Johnson Innovation – JJDC made?
- Johnson & Johnson Innovation – JJDC has 61 tracked investments, 4 of which have exited, including 4 dated in the last 24 months.
- What stage does Johnson & Johnson Innovation – JJDC invest at?
- Johnson & Johnson Innovation – JJDC invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Johnson & Johnson Innovation – JJDC focus on?
- Johnson & Johnson Innovation – JJDC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Johnson & Johnson Innovation – JJDC located?
- Johnson & Johnson Innovation – JJDC is headquartered in New Brunswick, US.
Images
Co-investors · 39
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
Aisling Capital is an investment firm focused on companies developing and commercializing innovative healthcare products, services, and technologies.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Foothill Ventures is a technology-focused venture fund based in Los Altos, California, run by a team with founder and operator backgrounds. It makes early-stage investments in frontier technology, particularly infrastructure and AI applications.
SR One Capital Management is a life sciences venture capital firm that takes a 'back-and-build' approach, providing entrepreneurs with human, intellectual, and financial resources. It emerged from the legacy SR One team formerly part of GSK.
Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
Hatteras Venture Partners is a venture capital firm focused on early-stage life sciences and healthcare companies, backing therapeutics, diagnostics, and businesses aiming to transform healthcare delivery and innovation.
Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.
Acrew Capital is a venture capital firm that emphasizes a team-based approach to investing, offering portfolio companies access to its full team.
▶27 more co-investors
VenrockAtlas VentureOUP (Osage University Partners)Illuminate VenturesBioGeneration VenturesThird Rock VenturesPivotal Life SciencesKurma PartnersLightstone VenturesNew Leaf Venture PartnersVida VenturesMedical Excellence CapitalHealthy VenturesVertex Ventures HCAvedro, Inc.Plug and Play VenturesWildcat Venture PartnersHighbury HoldingsFlare Capital PartnersCherubic VenturesFlagship PioneeringAdvent Life SciencesVantagePoint Capital Partners1955 CapitalVensana CapitalSante VenturesAberdare Ventures
Firms observed investing alongside Johnson & Johnson Innovation – JJDC, from public investor directories. Shared companies are the overlap with Johnson & Johnson Innovation – JJDC's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.